NCT06416436 Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients Status WITHDRAWN Phase PHASE1
NCT06410092 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001 Status RECRUITING Phase PHASE1
NCT06403735 A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06401356 An Extension Study for Patients Previously Enrolled in Studies With Pelabresib Status RECRUITING Phase PHASE3
NCT06398418 R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06394622 A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06384807 A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06383598 PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors Status RECRUITING Phase NA
NCT06368921 A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06364696 A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06349837 Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors Status RECRUITING Phase PHASE1
NCT06342336 HS-IT101 Injection in the Treatment of Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06337630 A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06336148 A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06326242 What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials Status RECRUITING Phase N/A